Evidence map›Paper›PMID 28574743›Full record

ArticleHuman vaccines & immunotherapeutics2017

Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey.

Ayşe Büyükcam, Hüseyin Güdücüoğlu, Kamuran Karaman, Venhar Gürbüz, Emil Aliyev, Ateş Kara, Mehmet Ceyhan

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ayşe Büyükcama Hacettepe University Faculty of Medicine , Department of Pediatrics, Unit of Infectious Diseases , Ankara , Turkey.
Hüseyin Güdücüoğlub Van Yüzüncü Yıl University Faculty of Medicine , Department of Medical Microbiology , Van , Turkey.
Kamuran Karamanc Van Yüzüncü Yıl University Faculty of Medicine , Department of Pediatrics , Van , Turkey.
Venhar Gürbüza Hacettepe University Faculty of Medicine , Department of Pediatrics, Unit of Infectious Diseases , Ankara , Turkey.
Emil Aliyevd Hacettepe University Faculty of Medicine , Department of Pediatrics , Ankara , Turkey.
Ateş Karaa Hacettepe University Faculty of Medicine , Department of Pediatrics, Unit of Infectious Diseases , Ankara , Turkey.
Mehmet Ceyhana Hacettepe University Faculty of Medicine , Department of Pediatrics, Unit of Infectious Diseases , Ankara , Turkey.
Hacettepe University · TRVan Yüzüncü Yıl Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive pneumococcal infections among children are a serious public health problem in many countries, including Turkey. Pneumococcal conjugate vaccine has been included in Turkey's National Immunization Programme since 2009. We report the first two pediatric cases of invasive pneumococcal infection due to non-vaccine serotype 15A after pneumococcal conjugate vaccine implementation in Turkey. It is essential to monitor the countries' own local seroepidemiologic data for detecting selective pressure of non-vaccine serotypes of S. pneumonia.

Indexed as

Immunization ProgramsSeroepidemiologic StudiesAdolescentHeptavalent Pneumococcal Conjugate VaccineHumansMalePneumococcal InfectionsPneumococcal VaccinesSerogroupSerotypingStreptococcus pneumoniaeTurkeyVaccines, ConjugateHeptavalent Pneumococcal Conjugate VaccinePneumococcal VaccinesVaccines, Conjugatechildinvasive pneumococcal infectionserotype 15Aserotype replacement

Identifiers

PMID28574743
PMCPMC5557239
OpenAlexW2621103025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.